Erasmus MC account plan
Innovative university medical center
At a glance
Erasmus MC is the university medical center of Rotterdam, with some 17,000 employees and 2025 operating income of €2,639.5 million.
Erasmus MC is the university medical center of Rotterdam, a public-law entity combining the Academisch Ziekenhuis Rotterdam and the Faculty of Medicine and Health Sciences of Erasmus University Rotterdam. It delivers tertiary care for complex and rare conditions, with 58 recognised expertise centres, alongside research and education; some 17,000 employees and more than 4,000 students work there. Most income comes from Dutch health-insurer contracts (€1,710.9 million in 2025), plus government contributions for academic care, the medical faculty and research. In 2025 operating income was €2,639.5 million and the result €116.4 million, with an average workforce of 13,598 FTE.
Business units
Erasmus MC Zorg (patient care)
€2,252.9 million operating income in 2025 (about 85% of the group)Hospital care sold mainly to Dutch health insurers, with an average of 10,942 FTE. Operating income rose €109 million (+5%) in 2025 on price indexation and the academic-care contribution, and the result reached €107.7 million as patient volumes and the share of tertiary care grew. Priorities include digital care through the Digizorg app and Virtual Ward, and regional concentration of oncology and vascular surgery.
Erasmus MC Onderzoek & Onderwijs (research and education)
€386.6 million operating income in 2025 (about 15% of the group)Research and medical education funded by the government faculty contribution (€140.8 million) and external research funding, with about 2,250 research projects at end 2025 and an average of 2,656 FTE. The result improved to +€8.7 million, but the report says the regular result is "not yet at the required level" and a roadmap toward a structurally healthy model was drawn up.
Admiraal de Ruyter Ziekenhuis (Adrz), Goes
General hospital in Zeeland, 100% held since 2017, which contributed €7.0 million of result in 2025. On 9 April 2026 the boards took the intended decision to make Adrz independent in the course of 2026, with medical cooperation continuing.
Erasmus MC Holding BV
Holds participations in spin-offs, care companies (dentistry, dermatology, travel clinic), campus and real estate, and the outpatient pharmacy, plus a 33% stake in the HollandPTC proton therapy centre; result €1.5 million in 2025.
Strategic priorities
- Tertiary, digital and appropriate care
- Koers28 (2024-2028) aims to concentrate high-complexity care on patients who need it most, using PROMs in more than 125 care pathways, the Digizorg app as the digital front door and the Virtual Ward.
- Digital and technological infrastructure
- A new cloud-based data platform, a cyber resilience programme shifted toward Protect/Recover, NEN 7510 and ISO 27001 certification, and Robotic Process Automation and AI to reduce workload.
- Retaining and attracting staff
- Strategic workforce planning, the DigiPLUS digital-skills programme, leadership days and a renewed leadership programme from 2026; the employer ranking rose from 9th to 3rd.
- Campus redevelopment
- Masterplan 2050 plans an "innovative healthtech campus", with designers contracted for the Sophia children's hospital renovation and new lab and education buildings.
- A healthy research and education model
- The Executive Board drew up a roadmap for a structurally healthy research and education segment, and from 2026 will measure the societal impact of research systematically.
Investments and deals
- Long-term investment programme
- The multi-year budget plans an average investment level of €193 million per year for 2026-2040 and €106 million for 2026, covering real estate, IT and medical equipment.
- 2025 capital spending
- €52 million was invested in 2025 in renovation, maintenance, equipment and ICT, €65 million below budget because the long-term housing plan moved more slowly.
- Proton therapy restructuring
- HollandPTC, 33% owned, was restructured at end 2025 with loans converted into equity and additional investment.
- Adrz independence
- The intended decision of 9 April 2026 makes the Goes hospital independent during 2026.
Challenges and risks
- Business continuity and staffing
- The top risk covers qualified staff, capacity, medical devices, supply chains and geopolitics; sick leave rose in 2025, and reports of aggression by patients and visitors rose from 173 to 237.
- Cybersecurity and technological continuity
- Both are in the 2025 top-10 risks, alongside privacy and responsible use of data and AI.
- Funding pressure
- The 2026 coalition agreement includes a planned cut to the academic-care availability contribution (BBAZ) and to medical postgraduate training; late availability of insurers' price lists is the main yearly liquidity risk.
- Rising costs
- Personnel costs rose €58.2 million to €1,307.2 million in 2025 on more staff and collective-labour-agreement measures, and rising investment will raise future depreciation.
Where a supplier can help
- Digital care and workload reduction
- The Digizorg app, Virtual Ward, RPA and AI are used to reduce workload; digital health and automation suppliers can tie their offer to the digital care priority and the staffing challenge.
- Cyber resilience
- Cybersecurity is a top-10 risk and the programme now focuses on Protect/Recover with extra back-up and a recovery environment; security, backup and recovery vendors fit this priority.
- Campus construction and equipment
- An average investment of €193 million per year for 2026-2040 in real estate, IT and medical equipment, and the Masterplan 2050 campus, open opportunities for construction, lab and medical equipment suppliers.
- Workforce and leadership development
- Strategic workforce planning, digital skills and a renewed leadership programme from 2026 create needs for training, HR technology and staffing support.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Erasmus MC?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Jaarverslag 2025 (annual report and financial statements 2025, audited version)
- Erasmus MC is the Rotterdam university medical center (umc), a public-law entity combining the Academisch Ziekenhuis Rotterdam and the Faculty of Medicine and Health Sciences of Erasmus University Rotterdam; three core tasks: patient care, research and education (valorisation as a fourth). About 17,000 employees and over 4,000 students.
- FY2025: result of €116.4 million on operating income of €2,639.5 million (2024: €71.7 million on €2,512.1 million); the board frames it as €116 million (4 percent) on €2.6 billion of revenue.
- Two reporting segments: Zorg (patient care) earned €107.7 million (2024: €85.2 million); O&O (research & education) turned from -€13.5 million to +€8.7 million, about half of the €22 million improvement from one-off items. Average workforce 13,598 FTE (Zorg 10,942, O&O 2,656).
- Income is dominated by the Zorgverzekeringswet (health-insurer contracts, €1,710.9 million, up €74 million on price indexation and better insurer agreements) and the academic-care availability contribution (bbaz, €297.7 million).
- Strategy Koers28 (2024-2028): focus on tertiary (complex/rare-disease) care, digital and appropriate care, research for societal challenges and education (ErasmusArts2030 curriculum); 58 recognised expertise centres for rare conditions, the most in the Netherlands.
- Digital front door: the Digizorg app is used by more than 35 care providers; Digital Referral via EHRs works with 63 providers; first Virtual Ward patient discharged early with hospital care at home; new cloud-based data platform; RPA and AI used to cut administrative workload.
- Large investment agenda: long-term housing plan to 2050 (Sophia children's hospital renovation, new labs/education buildings, Psychiatry); average investment of €193 million per year planned for 2026-2040 and €106 million budgeted for 2026, against only €52 million invested in 2025. Triple-A rating, equity €927 million, no new loans since 2018.
- Top risks: business continuity and staff shortages, cybersecurity, technological continuity, financial exploitation, privacy and integrity; the 2026 coalition agreement plans a cut to the BBAZ academic-care contribution and to medical postgraduate training.
- Governance: Executive Board chaired by Stefan Sleijfer (also dean, reappointed from 1 September 2025), CFO Paul Boomkamp, Dirk Schraven; Joke Boonstra left on 20 January 2026, replaced ad interim by Peter Sillevis Smitt. On 9 April 2026 the boards decided in principle to make the Admiraal de Ruyter Ziekenhuis (Goes) independent in the course of 2026.
Questions about Erasmus MC
What does Erasmus MC do?
Erasmus MC is the university medical center of Rotterdam. It delivers tertiary patient care for complex and rare conditions, conducts medical research and trains doctors and other health professionals.
What is Erasmus MC's revenue?
Operating income was €2,639.5 million in 2025 (2024: €2,512.1 million), with a result of €116.4 million. Patient care accounted for about 85% of operating income.
How many employees does Erasmus MC have?
Some 17,000 employees and more than 4,000 students; the average workforce was 13,598 FTE in 2025.
Who leads Erasmus MC?
Stefan Sleijfer chairs the Executive Board and is dean, with Paul Boomkamp as CFO and Dirk Schraven on the board. Marjan Trompetter chairs the Supervisory Board.
What is Erasmus MC's strategy?
Koers28 (2024-2028) sets ambitions to strengthen tertiary, digital and appropriate care, tackle societal challenges through research, invest in education, retain staff, and build an innovative digital infrastructure and effective operations.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)